Albemarle (ALB) Competitors

AdvanSix has a beta of 1.33, suggesting that its stock price is 33% more volatile than the S&P 500. Comparatively, Albemarle has a beta of 1.36, suggesting that its stock price is 36% more volatile than the S&P 500.

AdvanSix has a net margin of 3.24% compared to Albemarle's net margin of -10.74%. AdvanSix's return on equity of 6.97% beat Albemarle's return on equity.

AdvanSix presently has a consensus price target of $25.67, suggesting a potential downside of 1.89%. Albemarle has a consensus price target of $183.00, suggesting a potential downside of 6.15%. Given AdvanSix's higher probable upside, equities research analysts plainly believe AdvanSix is more favorable than Albemarle.

AdvanSix has higher earnings, but lower revenue than Albemarle. Albemarle is trading at a lower price-to-earnings ratio than AdvanSix, indicating that it is currently the more affordable of the two stocks.

86.4% of AdvanSix shares are held by institutional investors. Comparatively, 92.9% of Albemarle shares are held by institutional investors. 5.6% of AdvanSix shares are held by company insiders. Comparatively, 0.4% of Albemarle shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

In the previous week, Albemarle had 8 more articles in the media than AdvanSix. MarketBeat recorded 12 mentions for Albemarle and 4 mentions for AdvanSix. Albemarle's average media sentiment score of 1.03 beat AdvanSix's score of 0.51 indicating that Albemarle is being referred to more favorably in the news media.

AdvanSix pays an annual dividend of $0.64 per share and has a dividend yield of 2.4%. Albemarle pays an annual dividend of $1.62 per share and has a dividend yield of 0.8%. AdvanSix pays out 35.4% of its earnings in the form of a dividend. Albemarle pays out -28.2% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. AdvanSix has raised its dividend for 2 consecutive years and Albemarle has raised its dividend for 30 consecutive years.

92.9% of Albemarle shares are owned by institutional investors. Comparatively, 93.2% of Cabot shares are owned by institutional investors. 0.4% of Albemarle shares are owned by company insiders. Comparatively, 3.1% of Cabot shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Cabot has lower revenue, but higher earnings than Albemarle. Albemarle is trading at a lower price-to-earnings ratio than Cabot, indicating that it is currently the more affordable of the two stocks.

Albemarle has a beta of 1.36, indicating that its share price is 36% more volatile than the S&P 500. Comparatively, Cabot has a beta of 0.78, indicating that its share price is 22% less volatile than the S&P 500.

Cabot has a net margin of 8.62% compared to Albemarle's net margin of -10.74%. Cabot's return on equity of 22.82% beat Albemarle's return on equity.

Albemarle presently has a consensus price target of $183.00, indicating a potential downside of 6.15%. Cabot has a consensus price target of $73.75, indicating a potential downside of 6.61%. Given Albemarle's stronger consensus rating and higher probable upside, research analysts clearly believe Albemarle is more favorable than Cabot.

In the previous week, Albemarle had 1 more articles in the media than Cabot. MarketBeat recorded 12 mentions for Albemarle and 11 mentions for Cabot. Albemarle's average media sentiment score of 1.03 beat Cabot's score of 0.53 indicating that Albemarle is being referred to more favorably in the media.

Albemarle pays an annual dividend of $1.62 per share and has a dividend yield of 0.8%. Cabot pays an annual dividend of $1.80 per share and has a dividend yield of 2.3%. Albemarle pays out -28.2% of its earnings in the form of a dividend. Cabot pays out 31.5% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Albemarle has increased its dividend for 30 consecutive years and Cabot has increased its dividend for 14 consecutive years.

Chemours has a net margin of -6.41% compared to Albemarle's net margin of -10.74%. Chemours' return on equity of 41.75% beat Albemarle's return on equity.

Albemarle has a beta of 1.36, indicating that its share price is 36% more volatile than the S&P 500. Comparatively, Chemours has a beta of 1.47, indicating that its share price is 47% more volatile than the S&P 500.

In the previous week, Albemarle had 3 more articles in the media than Chemours. MarketBeat recorded 12 mentions for Albemarle and 9 mentions for Chemours. Albemarle's average media sentiment score of 1.03 beat Chemours' score of 0.45 indicating that Albemarle is being referred to more favorably in the media.

92.9% of Albemarle shares are owned by institutional investors. Comparatively, 76.3% of Chemours shares are owned by institutional investors. 0.4% of Albemarle shares are owned by insiders. Comparatively, 0.9% of Chemours shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Chemours has higher revenue and earnings than Albemarle. Albemarle is trading at a lower price-to-earnings ratio than Chemours, indicating that it is currently the more affordable of the two stocks.

Albemarle presently has a consensus price target of $183.00, indicating a potential downside of 6.15%. Chemours has a consensus price target of $20.70, indicating a potential downside of 25.89%. Given Albemarle's stronger consensus rating and higher possible upside, equities analysts clearly believe Albemarle is more favorable than Chemours.

Albemarle pays an annual dividend of $1.62 per share and has a dividend yield of 0.8%. Chemours pays an annual dividend of $0.35 per share and has a dividend yield of 1.3%. Albemarle pays out -28.2% of its earnings in the form of a dividend. Chemours pays out -14.1% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Albemarle has increased its dividend for 30 consecutive years.

98.9% of Celanese shares are owned by institutional investors. Comparatively, 92.9% of Albemarle shares are owned by institutional investors. 0.3% of Celanese shares are owned by insiders. Comparatively, 0.4% of Albemarle shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Celanese currently has a consensus price target of $66.00, indicating a potential downside of 4.57%. Albemarle has a consensus price target of $183.00, indicating a potential downside of 6.15%. Given Celanese's stronger consensus rating and higher probable upside, research analysts clearly believe Celanese is more favorable than Albemarle.

Celanese has a beta of 0.81, meaning that its stock price is 19% less volatile than the S&P 500. Comparatively, Albemarle has a beta of 1.36, meaning that its stock price is 36% more volatile than the S&P 500.

Albemarle has a net margin of -10.74% compared to Celanese's net margin of -12.15%. Celanese's return on equity of 8.75% beat Albemarle's return on equity.

Celanese pays an annual dividend of $0.12 per share and has a dividend yield of 0.2%. Albemarle pays an annual dividend of $1.62 per share and has a dividend yield of 0.8%. Celanese pays out -1.1% of its earnings in the form of a dividend. Albemarle pays out -28.2% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Albemarle has raised its dividend for 30 consecutive years. Albemarle is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

In the previous week, Celanese had 3 more articles in the media than Albemarle. MarketBeat recorded 15 mentions for Celanese and 12 mentions for Albemarle. Albemarle's average media sentiment score of 1.03 beat Celanese's score of 0.41 indicating that Albemarle is being referred to more favorably in the news media.

Albemarle has lower revenue, but higher earnings than Celanese. Albemarle is trading at a lower price-to-earnings ratio than Celanese, indicating that it is currently the more affordable of the two stocks.